Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 16/04/2012
PIL Aprovel 300mg film coated tablets (sanofi-aventis)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 05/07/2011 and displayed until 16/04/2012
Reasons for adding or updating:
  • Change to side-effects
  • PIL Submitted in error
Updated on 24/08/2009 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 05/09/2008 and displayed until 24/08/2009
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 11/05/2004 and displayed until 05/09/2008
Reasons for adding or updating:
  • PIL Product / presentation discontinued
  • Change to side-effects
Updated on 16/10/2002 and displayed until 11/05/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  irbesartan